Contact Us
PharmaSUG China 2021

WeChat scan to contact the organizer immediately

Weibo
WeChat
PharmaSUG China 2021

You can share it to WeChat via the Qr code.

Events
PharmaSUG China 2021

Enter the applet sharing event using WeChat scan.

Registration
On preparation
Tickets are on sale
The event ends
Choose ticket
Type
07/24 before (¥) Now - 08/13(¥) Original
Quantity
PharmaSUG China Conference 2021
2,412 2,881 3,350
0
This Registration Form is for attendees who do need a FaPiao. This system will issue a FaPiao when you complete your Registration.

For those who do NOT need FaPiao, please return to our website and choose the other registration link to CVENT.

Refund Description:
Cancellation admin fee $50/¥335. After 25June2021, registration cannot be canceled. Replacement is allowed.

Price
0
Details

PharmaSUG China is the premier event of the year for statistical programmers, statisticians, data managers, researchers, and others who analyze data in the life sciences. The 2021 conference committee is working hard at planning another fabulous event featuring two days of paper presentations, hands-on workshops, live demonstrations, and much more.

For Information Update
Please enter the cellphone or the e-mail you've written when you buy the ticket.
Pre-Conference Trainer
  • Head of Regulatory Operations of J&J China and North Asia
    Feng has ten years of work experience in the field of regulatory operations. Currently he is working for Johnson & Johnson as the Head of Regulatory Operations in China and North Asia, and worked for Bayer and Novartis in registration and operation related businesses prior to join J&J. Previously, he represented the company in eCTD testing organized by CDE and completed the testing work.
  • Head of Regulatory Operations and Compliance of Novartis GDD China RA
    Alice Zhou has worked for Novartis China over 20 years in Public Affairs, Business Development and Regulatory Affairs. Her current role is as Head of Regulatory Operations and Compliance of Novartis GDD China RA. She started the role as RA Operations Group Manager in 2009 and set up the Ops & Compliance group in Novartis RA. Her team has been working with global RA Ops team in preparing China eCTD and mirrored global submission management process on NDA/CTA filing in China since 2013.
  • Director, Statistical Analysis, at dMed Biopharmaceutical Co., Ltd.
    Director, Statistical Analysis, at dMed Biopharmaceutical Co., Ltd. He has 14+ years extensive statistical analysis experience in all phases of clinical trials, is familiar with different kinds of programming languages and system tools in clinical research. Before he joined dMed, he was Manager of SAS Programming at Johnson & Johnson China since 2009. Prior to that, he was associate manager of SAS programming for four years at Global Research Services, LLC. He is Vice Chair and team lead for the SDTM group in C3C (China CDISC Coordinating Committee). He has very extensive experience using CDISC fundamental data standards such as CDASH, SDTM, ADaM, Controlled Terminology and define.xml. He became a CDISC authorized SDTM Instructor in early 2016.
  • Statistical Programming Analyst at Janssen China R&D
    Statistical Programming Analyst at Janssen China R&D with 3 years programming experience in pharmaceutical industry supporting Oncology studies. Her expertise in R is data visualization, focusing on ggplot2. As R trainer, she delivered R base trainings to APAC programming colleagues. She also organized cross-sector R sharing seminar and facilitated workshops to build a dynamic R learning environment for R beginners. She enjoys exploring elegant solutions to create graphs, the process that taking flat data and bringing it to life.
  • Statistical Programming Lead, at Janssen China R&D
    Statistical Programming Lead, at Janssen China R & D. He has 9+ years of experiences in drug development industry. He joined Janssen in 2017 and accumulated extensive statistical programming and analysis experiences spanning phase I to phase III trials, including eSub, data pooling, FDA/EMA/and other healthy authority ad-hoc requests and publication support requests. Aside from projects, Jerry is pioneer in departmental R initiatives, his key accomplishments include Shiny APP development and several pilot projects with TLFs in R static and interactive mode. Jerry is passionate in coding with various languages, particularly R package and Shiny app development are his expertise. He finds the automation using R in our daily work is not only a fancy idea and R really lights up this solution for efficiency and cross-function connections, which make this R journey very promising and evolutionary in future of industry. Prior to Janssen, he worked at Pfizer R&D as Technical Supervisor, Clinical Programming.
  • Director, Technical Operation Lead of Clinical Data Management at dMed Biopharmaceutical Co., Ltd.
    He has 15+ years of experiences in new drug R&D industry, he is enthusiastic about software development and data standards implementation in this area. He joined dMed in 2017, he and his team developed Clinical Metadata Repository (MDR) and many other programs to enable end-to-end automation of clinical data workflows. Before he joined dMed, he was Manager, Technical Process Lead of Clinical Data Management at Pfizer China R&D Center since 2009, in this position, he was working in data standards and data visualization team.
  • Manager, Clinical Data Management, at dMed Biopharmaceutical Co., Ltd.
    He has 10+ years of experiences in clinical data management, focuses on the application of clinical research-related software systems, as well as the development of automated tools, he is familiar with both SAS and Python, he has also involved in central monitoring software setups in a couple of years. He joined dMed in 2018, prior to that, he worked at Pfizer R&D China Center.
  • Sponsors
    Platinum
    PharmaSUG China 2021
    PharmaSUG China 2021
    PharmaSUG China 2021
    Gold
    PharmaSUG China 2021
    PharmaSUG China 2021
    PharmaSUG China 2021
    PharmaSUG China 2021
    PharmaSUG China 2021